| P2093 | author name string | Lisa Baker | |
| | Jesus A Angulo | |
| | Carolyn Diaz | |
| | Ina Mexhitaj | |
| | Lauriaselle Afanador | |
| | Dalila Ordonez | |
| P2860 | cites work | How addictive drugs disrupt presynaptic dopamine neurotransmission | Q24631269 |
| | Methamphetamine toxicity and messengers of death | Q24647617 |
| | Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009 | Q24653924 |
| | The newly synthesized pool of dopamine determines the severity of methamphetamine-induced neurotoxicity | Q28261448 |
| | Mechanisms of amphetamine action revealed in mice lacking the dopamine transporter | Q28263277 |
| | Amphetamine redistributes dopamine from synaptic vesicles to the cytosol and promotes reverse transport | Q28301517 |
| | Somatostatin release by glutamate in vivo is primarily regulated by AMPA receptors | Q28363699 |
| | Methamphetamine administration causes overexpression of nNOS in the mouse striatum | Q28369032 |
| | Methamphetamine increases dopamine transporter higher molecular weight complex formation via a dopamine- and hyperthermia-associated mechanism | Q28571044 |
| | nNOS inhibitors attenuate methamphetamine-induced dopaminergic neurotoxicity but not hyperthermia in mice | Q31440673 |
| | Modulation of methamphetamine-induced nitric oxide production by neuropeptide Y in the murine striatum | Q33575295 |
| | Disparity in the temporal appearance of methamphetamine-induced apoptosis and depletion of dopamine terminal markers in the striatum of mice | Q33915570 |
| | Advances in understanding neuronal somatostatin receptors | Q33927953 |
| | Distinct mechanisms mediating methamphetamine-induced neuronal apoptosis and dopamine terminal damage share the neuropeptide substance p in the striatum of mice | Q33944343 |
| | Histological evidence supporting a role for the striatal neurokinin-1 receptor in methamphetamine-induced neurotoxicity in the mouse brain | Q33958185 |
| | Somatostatin receptor 1 and 5 double knockout mice mimic neurochemical changes of Huntington's disease transgenic mice | Q34017941 |
| | Methamphetamine induces striatal neurokinin‐1 receptor endocytosis primarily in somatostatin/NPY/NOS interneurons and the role of dopamine receptors in mice | Q34388424 |
| | Fluoro-Jade: a novel fluorochrome for the sensitive and reliable histochemical localization of neuronal degeneration | Q34421291 |
| | Synergism between methamphetamine and the neuropeptide substance P on the production of nitric oxide in the striatum of mice | Q34459294 |
| | Protective effect of the radical scavenger edaravone against methamphetamine-induced dopaminergic neurotoxicity in mouse striatum | Q34568490 |
| | Mechanisms of methamphetamine-induced dopaminergic neurotoxicity | Q35594901 |
| | Nitric oxide neurotoxicity in neurodegenerative diseases | Q35650937 |
| | Somatostatin presynaptically inhibits both GABA and glutamate release onto rat basal forebrain cholinergic neurons | Q35748286 |
| | Functional diversity and specificity of neostriatal interneurons. | Q35974955 |
| | The basics about nitric oxide | Q36049486 |
| | Nitric oxide and neurological disorders | Q36049498 |
| | Differential regulation of NMDAR1 mRNA and protein by estradiol in the rat hippocampus. | Q36821786 |
| | Somatostatin: an endogenous antiepileptic | Q37067748 |
| | Connection between the striatal neurokinin-1 receptor and nitric oxide formation during methamphetamine exposure | Q37383390 |
| | Methamphetamine - Effects on Human Performance and Behavior. | Q38563382 |
| | Regulation of neuronal nitric-oxide synthase activity by somatostatin analogs following SST5 somatostatin receptor activation | Q40281065 |
| | Striatal interneurones: chemical, physiological and morphological characterization | Q40991491 |
| | Nitric oxide neurotoxicity | Q41115083 |
| | Oxidative damage and tyrosine nitration from peroxynitrite | Q41129375 |
| | Competitive and noncompetitive antagonists at N-methyl-D-aspartate receptors protect against methamphetamine-induced dopaminergic damage in mice | Q41133663 |
| | Neostriatal cell subtypes and their functional roles | Q41412474 |
| | Somatostatin receptor 2 knockout/lacZ knockin mice show impaired motor coordination and reveal sites of somatostatin action within the striatum | Q42441399 |
| | Neuronal nitric oxide synthase: a substrate for SHP-1 involved in sst2 somatostatin receptor growth inhibitory signaling. | Q42508870 |
| | Role of dopamine transporter in methamphetamine-induced neurotoxicity: evidence from mice lacking the transporter. | Q42541545 |
| | The neuronal nitric oxide synthase inhibitor, 7-nitroindazole, protects against methamphetamine-induced neurotoxicity in vivo. | Q42553235 |
| | Somatostatin receptor subtype-dependent regulation of nitric oxide release: involvement of different intracellular pathways. | Q42636717 |
| | MK-801 prevents methamphetamine-induced striatal dopamine damage and reduces extracellular dopamine overflow | Q43558097 |
| | Methamphetamine causes differential regulation of pro-death and anti-death Bcl-2 genes in the mouse neocortex | Q43693008 |
| | Methamphetamine causes widespread apoptosis in the mouse brain: evidence from using an improved TUNEL histochemical method | Q43725939 |
| | Methamphetamine induces neuronal apoptosis via cross-talks between endoplasmic reticulum and mitochondria-dependent death cascades | Q44760486 |
| | Effect of somatostatin on nitric oxide production in human retinal pigment epithelium cell cultures | Q44865858 |
| | Activation of somatostatin receptor (sst 5) protects the rat retina from AMPA-induced neurotoxicity. | Q45940275 |
| | Modulation of the neuronal response to ischaemia by somatostatin analogues in wild-type and knock-out mouse retinas. | Q46485505 |
| | Methamphetamine neurotoxicity: dissociation of striatal dopamine terminal damage from parietal cortical cell body injury | Q46553119 |
| | Somatostatin in medium-sized aspiny interneurons of striatum is responsible for their preservation in quinolinic acid and N-methyl-D-asparate-induced neurotoxicity | Q46592729 |
| | Effect of intravitreal administration of somatostatin and sst2 analogs on AMPA-induced neurotoxicity in rat retina | Q46662954 |
| | The role of nitric oxide and cGMP in somatostatin's protection against retinal ischemia | Q46825640 |
| | Somatostatinergic modulation of firing pattern and calcium-activated potassium currents in medium spiny neostriatal neurons | Q48260625 |
| | Regulation of neuronal nitric oxide synthase and identification of novel nitric oxide signaling pathways | Q48291009 |
| | The effects of methamphetamine on the production of free radicals and oxidative stress | Q48379473 |
| | Brain dopamine neurotoxicity in baboons treated with doses of methamphetamine comparable to those recreationally abused by humans: evidence from [11C]WIN-35,428 positron emission tomography studies and direct in vitro determinations. | Q48558719 |
| | Mechanisms of reduced striatal NMDA excitotoxicity in type I nitric oxide synthase knock-out mice | Q48630156 |
| | Somatostatin inhibits excitatory transmission at rat hippocampal synapses via presynaptic receptors. | Q48703336 |
| | Effect of methamphetamine on glutamate-positive neurons in the adult and developing rat somatosensory cortex | Q48951476 |
| | Effect of acute and chronic methamphetamine treatment on tyrosine hydroxylase activity in brain and adrenal medulla. | Q51120442 |
| | Role for excitatory amino acids in methamphetamine-induced nigrostriatal dopaminergic toxicity. | Q51757758 |
| | Ultrastructural correlates of functional relationships between nigral dopaminergic or cortical afferent fibers and neuropeptide Y-containing neurons in the rat striatum | Q62031260 |
| | Blockade of neuronal nitric oxide synthase protects against excitotoxicity in vivo | Q71038834 |
| | Neuroprotective effect of somatostatin on nonapoptotic NMDA-induced neuronal death: role of cyclic GMP | Q71934877 |
| | Long-term effects of multiple doses of methamphetamine on tryptophan hydroxylase and tyrosine hydroxylase activity in rat brain | Q72426971 |
| | Chemical anatomy of striatal interneurons in normal individuals and in patients with Huntington's disease | Q73209561 |
| | Effects of somatostatin, octreotide and cortistatin on ischaemic neuronal damage following permanent middle cerebral artery occlusion in the rat | Q73320030 |
| | Somatostatin release in the hippocampus in the kindling model of epilepsy: a microdialysis study | Q73812119 |
| | Colocalization of somatostatin receptors with DARPP-32 in cortex and striatum of rat brain | Q82676429 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | toxic encephalopathy | Q7830379 |
| | striatum | Q1319792 |
| | neurotoxicity | Q3338704 |
| P304 | page(s) | 38-47 | |
| P577 | publication date | 2013-03-19 | |
| P1433 | published in | Brain Research | Q4955782 |
| P1476 | title | The role of the neuropeptide somatostatin on methamphetamine and glutamate-induced neurotoxicity in the striatum of mice | |
| P478 | volume | 1510 | |